About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Risk of Death After Giving Birth can be Reduced by Biomarker Test for Peripartum Cardiomyopathy

by Kathy Jones on May 18, 2014 at 4:44 PM
 Risk of Death After Giving Birth can be Reduced by Biomarker Test for Peripartum Cardiomyopathy

Biomarkers that can be used to develop a screening test to detect Peripartum Cardiomyopathy (PPCM) have been discovered by cardiologists. The former is a life-threatening disorder that is the primary cause of mortality in pregnant women in developing countries.

The results, which can lead to the immediate treatment of PPCM in new mothers and a significant reduction in mortality, were presented at Heart Failure 2014, which opened the World Congress on Acute Heart Failure in Athens the 17 to the 20 May. "For pregnant women there are two major causes of death: massive hemorrhage and PPCM, and it is a very sad situation because a time of great happiness turns to great sorrow and the new baby and the father are left alone," said study co-author Professor Alexandre Mebazaa, from the Hopital Lariboisiere, Paris. "Here we have found a way to detect rather quickly whether the woman has PPCM and to treat it quickly and efficiently." PPCM is the leading cause of death in women who are pregnant or have just given birth in Haiti, South African and Egypt, according to the study's authors.

Advertisement

Treatment was often delayed because it was difficult to know whether the women were experiencing normal symptoms of pregnancy or PPCM. The new discovery will allow doctors to administer a blood test to determine whether the woman has PPCM and begin effective treatment immediately. "There's an urgent need for biomarkers of PPCM since the condition can be hard to differentiate from the normal symptoms of pregnancy that include dyspnoea, oedema and palpitations", said Professor Karen Sliwa, a co-author from the University of Cape Town, South Africa. The authors hypothesized that since angiogenesis and relaxin-2 pathways are altered in PPCM the biomarkers ratio of these two pathways placental growth factors/sFlt-1 and relaxin-2 could be used to discriminate PPCM among peripartum women.

In the study, plasma was withdrawn from 77 PPCM patients, 75 healthy peripartum women, 25 breast feeding mothers, and 65 non-pregnant acute heart failure (HF) patients and tested for levels of cardiovascular (NT-proBNP), anti- (sFlt-1) and angiogenic [Placental (PlGF) or vascular endothelial (VEGF)] .
Advertisement

Results showed that compared to the other groups, PPCM patients had significantly higher levels of NT-proBNP, lower levels of plasma relaxin-2, and that the sFlt-1/PlGF ratio and sFlt-1/VEGF ratio were statistically lower.

"The next step will be to confirm our findings in a larger cohort and if they hold we could go on to develop a bed side test similar to NT-pro BNP in HF," said Professor Sliwa.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Women Health News

Placenta Unravels Anonymous Miscarriages & Stillbirths
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Predictive Tools for Pregnancy Complications Related to Fetal Growth
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
Urine Ovulation Test may Raise your Chances of Pregnancy
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
Premature Ovary Removal Linked to Accelerated Aging
Oophorectomy's adverse effects raise questions about risk-benefit balance, especially for average ovarian cancer risk women.
Stem Cells Offer Hope for PCOS Root Causes
This study highlights the ovarian resilience achieved through stem cell treatments, providing hope for women struggling with fertility problems related to PCOS.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Risk of Death After Giving Birth can be Reduced by Biomarker Test for Peripartum Cardiomyopathy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests